IDT has expanded its Coralville manufacturing footprint, boosting synthesis capacity by threefold, to meet the rapidly growing demand for MRD and NGS-based oncology research workflows
Read moreAfter more than a decade of research, a new-generation CAR-T therapy developed by VHIO, in collaboration with the Hospital del Mar Research Institute, has been administered to patients for the first t...
Read moreThe study presents a strategy for ‘programming’ these shape changes by controlling how cells orient themselves within the tissue through chemical patterns.
Read more20% of breast cancer diagnoses are actually precancerous lesions. As it is not yet possible to know which ones will progress to cancer, the vast majority are treated as if they were already cancerous
Read moreKidney dysfunction disrupts lipid metabolism and accelerates atherosclerosis
Read moreEn este trabajo, publicado en la revista Journal of Antimicrobial Chemotherapy, se ha observado que los tratamientos de última generación podrían mejorar a los antibióticos tradicionales frente a ...
Read moreLa diabetes mellitus se asocia a un incremento significativo del riesgo cardiovascular, constituyendo la principal causa de morbimortalidad en estos pacientes. Además de la hiperglucemia crónica, ot...
Read moreEl tratamiento con Zongertinib ya demostró sus beneficios como terapia de segunda línea en este tipo de cáncer
Read moreThe search for safer, more effective medicines increasingly depends on understanding how biological systems respond to disease, genetic variation, and therapeutic interventions at the molecular level....
Read moreTo mark the 25th anniversary of a landmark framework in cancer research, Cell has published a special issue devoted to the biological processes that drive cancer and their therapeutic implications.
Read moreAstaxanthin is a naturally occurring xanthophyll carotenoid that has gained significant scientific attention due to its exceptional antioxidant activity, molecular stability and broad application pote...
Read moreWith this capital injection, the biotechnology company covers its financial requirements to complete the preclinical development and the first clinical trial of ITR-251, a novel drug for the treatment...
Read more